BioCentury | Aug 22, 2011
Financial News

Embera financial update

...total raised in the round to $5.8 million. Existing investors Louisiana Ventures; Louisiana Fund; and Themelios Ventures...
BioCentury | Jun 13, 2011
Financial News

Esperance completes venture financing

...Cancer Date completed: 6/1/11 Type: Venture financing Raised: Not disclosed Investors: Sanofi ; Louisiana Fund; Themelios Ventures...
BioCentury | Feb 2, 2009
Emerging Company Profile

Corporate Profile

Esperance Pharmaceuticals Inc. Baton Rouge, La. Technology: Fusion proteins consisting of a tumor-seeking hormone receptor ligand conjugated to a cytotoxin Disease focus: Cancer Clinical status: Preclinical Founded: 2006 by William Hansel, Carola Leuschner and Fred...
Items per page:
1 - 3 of 3
BioCentury | Aug 22, 2011
Financial News

Embera financial update

...total raised in the round to $5.8 million. Existing investors Louisiana Ventures; Louisiana Fund; and Themelios Ventures...
BioCentury | Jun 13, 2011
Financial News

Esperance completes venture financing

...Cancer Date completed: 6/1/11 Type: Venture financing Raised: Not disclosed Investors: Sanofi ; Louisiana Fund; Themelios Ventures...
BioCentury | Feb 2, 2009
Emerging Company Profile

Corporate Profile

Esperance Pharmaceuticals Inc. Baton Rouge, La. Technology: Fusion proteins consisting of a tumor-seeking hormone receptor ligand conjugated to a cytotoxin Disease focus: Cancer Clinical status: Preclinical Founded: 2006 by William Hansel, Carola Leuschner and Fred...
Items per page:
1 - 3 of 3